Royalty Pharma PLCNASDAQ:RPRX
- LAST PRICE26.9000
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots26.6900/ 1
- Ask / Lots27.1700/ 1
- Open / Previous Close27.0200 / 26.9000
- Day Range
- 52 Week Range
- Volume2,678,803
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RPRX |
|---|---|---|
| 09:32 ET | 17372 | 27 |
| 09:34 ET | 2874 | 27.02 |
| 09:36 ET | 4593 | 27.1 |
| 09:38 ET | 1600 | 27.07 |
| 09:39 ET | 2145 | 27.08 |
| 09:41 ET | 1476 | 27.035 |
| 09:43 ET | 3668 | 26.995 |
| 09:45 ET | 1506 | 27.01 |
| 09:48 ET | 604 | 26.93 |
| 09:50 ET | 2372 | 27.02 |
| 09:52 ET | 6774 | 27.02 |
| 09:54 ET | 6417 | 27.06 |
| 09:56 ET | 48095 | 27 |
| 09:57 ET | 4285 | 26.945 |
| 09:59 ET | 1100 | 26.935 |
| 10:01 ET | 3041 | 26.96 |
| 10:03 ET | 7209 | 26.89 |
| 10:06 ET | 2195 | 26.92 |
| 10:08 ET | 3475 | 26.89 |
| 10:10 ET | 105837 | 26.905 |
| 10:12 ET | 9576 | 26.89 |
| 10:14 ET | 6092 | 26.87 |
| 10:15 ET | 3643 | 26.95 |
| 10:17 ET | 1296 | 26.99 |
| 10:19 ET | 10521 | 26.99 |
| 10:21 ET | 5122 | 26.965 |
| 10:24 ET | 4793 | 26.965 |
| 10:26 ET | 7160 | 26.965 |
| 10:28 ET | 35424 | 27 |
| 10:30 ET | 12610 | 27.03 |
| 10:32 ET | 6201 | 27.07 |
| 10:33 ET | 6307 | 27.09 |
| 10:35 ET | 4174 | 27.07 |
| 10:37 ET | 923 | 27.07 |
| 10:39 ET | 2300 | 27.065 |
| 10:42 ET | 1881 | 27.09 |
| 10:44 ET | 3709 | 27.08 |
| 10:46 ET | 1400 | 27.08 |
| 10:48 ET | 1418 | 27.065 |
| 10:50 ET | 400 | 27.05 |
| 10:51 ET | 2831 | 27.055 |
| 10:53 ET | 3494 | 27.025 |
| 10:55 ET | 503 | 27.015 |
| 10:57 ET | 5427 | 27 |
| 11:00 ET | 3405 | 26.985 |
| 11:02 ET | 2300 | 26.985 |
| 11:04 ET | 1600 | 26.975 |
| 11:06 ET | 5626 | 26.99 |
| 11:08 ET | 50283 | 27.01 |
| 11:09 ET | 25757 | 26.93 |
| 11:11 ET | 39696 | 26.975 |
| 11:13 ET | 2393 | 26.985 |
| 11:15 ET | 5095 | 26.92 |
| 11:18 ET | 2007 | 26.91 |
| 11:20 ET | 400 | 26.905 |
| 11:22 ET | 6007 | 26.93 |
| 11:24 ET | 3320 | 26.9083 |
| 11:26 ET | 2504 | 26.9 |
| 11:27 ET | 2474 | 26.915 |
| 11:29 ET | 100 | 26.895 |
| 11:31 ET | 3278 | 26.865 |
| 11:33 ET | 1000 | 26.835 |
| 11:36 ET | 1811 | 26.83 |
| 11:38 ET | 6705 | 26.8 |
| 11:40 ET | 1000 | 26.79 |
| 11:42 ET | 2230 | 26.83 |
| 11:44 ET | 2045 | 26.849 |
| 11:45 ET | 2406 | 26.85 |
| 11:47 ET | 9072 | 26.87 |
| 11:49 ET | 6028 | 26.845 |
| 11:51 ET | 1098 | 26.83 |
| 11:54 ET | 4577 | 26.82 |
| 11:56 ET | 2477 | 26.79 |
| 11:58 ET | 5113 | 26.74 |
| 12:00 ET | 100 | 26.745 |
| 12:02 ET | 500 | 26.745 |
| 12:03 ET | 7591 | 26.77 |
| 12:05 ET | 4432 | 26.8 |
| 12:07 ET | 18564 | 26.795 |
| 12:09 ET | 12312 | 26.82 |
| 12:12 ET | 16560 | 26.89 |
| 12:14 ET | 8509 | 26.88 |
| 12:16 ET | 13108 | 26.91 |
| 12:18 ET | 15530 | 26.915 |
| 12:20 ET | 10436 | 26.9 |
| 12:21 ET | 7508 | 26.905 |
| 12:23 ET | 8188 | 26.925 |
| 12:25 ET | 2070 | 26.92 |
| 12:27 ET | 8280 | 26.9192 |
| 12:30 ET | 2200 | 26.915 |
| 12:32 ET | 8664 | 26.91 |
| 12:34 ET | 3283 | 26.915 |
| 12:36 ET | 9208 | 26.925 |
| 12:38 ET | 3800 | 26.92 |
| 12:39 ET | 3932 | 26.92 |
| 12:41 ET | 8341 | 26.91 |
| 12:43 ET | 6767 | 26.895 |
| 12:45 ET | 3512 | 26.905 |
| 12:48 ET | 5726 | 26.93 |
| 12:50 ET | 3301 | 26.955 |
| 12:52 ET | 7635 | 26.94 |
| 12:54 ET | 4997 | 26.945 |
| 12:56 ET | 6751 | 26.95 |
| 12:57 ET | 612 | 26.9487 |
| 12:59 ET | 5500 | 26.94 |
| 01:01 ET | 9273 | 26.96 |
| 01:03 ET | 5709 | 26.965 |
| 01:06 ET | 2431 | 26.9601 |
| 01:08 ET | 4429 | 26.985 |
| 01:10 ET | 3377 | 26.99 |
| 01:12 ET | 7417 | 26.9991 |
| 01:14 ET | 4550 | 27.005 |
| 01:15 ET | 5454 | 27.005 |
| 01:17 ET | 8128 | 27.015 |
| 01:19 ET | 6949 | 27.01 |
| 01:21 ET | 2160 | 26.995 |
| 01:24 ET | 11139 | 27.03 |
| 01:26 ET | 2900 | 27.02 |
| 01:28 ET | 8038 | 27.03 |
| 01:30 ET | 900 | 27.03 |
| 01:32 ET | 3137 | 27.05 |
| 01:33 ET | 7954 | 27.045 |
| 01:35 ET | 7226 | 27.07 |
| 01:37 ET | 3317 | 27.075 |
| 01:39 ET | 7593 | 27.065 |
| 01:42 ET | 7491 | 27.06 |
| 01:44 ET | 5610 | 27.055 |
| 01:46 ET | 1200 | 27.055 |
| 01:48 ET | 9366 | 27.05 |
| 01:50 ET | 8193 | 27.0599 |
| 01:51 ET | 4423 | 27.055 |
| 01:53 ET | 7044 | 27.0292 |
| 01:55 ET | 9059 | 27.04 |
| 01:57 ET | 4006 | 27.03 |
| 02:00 ET | 7047 | 27.035 |
| 02:02 ET | 6540 | 27.055 |
| 02:04 ET | 4800 | 27.06 |
| 02:06 ET | 10556 | 27.06 |
| 02:08 ET | 1564 | 27.05 |
| 02:09 ET | 9565 | 27.055 |
| 02:11 ET | 11315 | 27.07 |
| 02:13 ET | 3297 | 27.065 |
| 02:15 ET | 2757 | 27.065 |
| 02:18 ET | 7822 | 27.075 |
| 02:20 ET | 4571 | 27.07 |
| 02:22 ET | 5069 | 27.07 |
| 02:24 ET | 9705 | 27.055 |
| 02:26 ET | 9308 | 27.055 |
| 02:27 ET | 8062 | 27.059 |
| 02:29 ET | 1349 | 27.05 |
| 02:31 ET | 8354 | 27.03 |
| 02:33 ET | 8794 | 27.04 |
| 02:36 ET | 5948 | 27.035 |
| 02:38 ET | 3686 | 27.035 |
| 02:40 ET | 10134 | 27 |
| 02:42 ET | 4690 | 27.025 |
| 02:44 ET | 3973 | 27.02 |
| 02:45 ET | 10102 | 27.01 |
| 02:47 ET | 7403 | 26.96 |
| 02:49 ET | 7133 | 26.94 |
| 02:51 ET | 1486 | 26.945 |
| 02:54 ET | 7141 | 26.9 |
| 02:56 ET | 3677 | 26.9 |
| 02:58 ET | 1738 | 26.885 |
| 03:00 ET | 1323 | 26.89 |
| 03:02 ET | 10019 | 26.855 |
| 03:03 ET | 4174 | 26.86 |
| 03:05 ET | 9014 | 26.895 |
| 03:07 ET | 3541 | 26.885 |
| 03:09 ET | 930 | 26.8801 |
| 03:12 ET | 1851 | 26.89 |
| 03:14 ET | 4879 | 26.88 |
| 03:16 ET | 6596 | 26.885 |
| 03:18 ET | 8773 | 26.9 |
| 03:20 ET | 5560 | 26.92 |
| 03:21 ET | 7095 | 26.92 |
| 03:23 ET | 8898 | 26.91 |
| 03:25 ET | 2350 | 26.905 |
| 03:27 ET | 14174 | 26.905 |
| 03:30 ET | 12338 | 26.885 |
| 03:32 ET | 7018 | 26.905 |
| 03:34 ET | 13144 | 26.9 |
| 03:36 ET | 2938 | 26.895 |
| 03:38 ET | 12531 | 26.91 |
| 03:39 ET | 12718 | 26.92 |
| 03:41 ET | 11182 | 26.915 |
| 03:43 ET | 65198 | 26.91 |
| 03:45 ET | 25987 | 26.9 |
| 03:48 ET | 31478 | 26.865 |
| 03:50 ET | 32401 | 26.855 |
| 03:52 ET | 52008 | 26.895 |
| 03:54 ET | 55508 | 26.92 |
| 03:56 ET | 70987 | 26.905 |
| 03:57 ET | 72999 | 26.89 |
| 03:59 ET | 504011 | 26.9 |
Jun 4, 2024
Royalty Pharma to Present at the Goldman Sachs 45th Annual Global Healthcare Conference, from 4:15PM ET on Tuesday Jun 04, 2024 by Dow Jones
4:15PM ET on Tuesday Jun 04, 2024 by Dow Jones
Jun 3, 2024
Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes, from 5:15PM ET on Monday Jun 03, 2024 by Dow Jones
5:15PM ET on Monday Jun 03, 2024 by Dow JonesPress Release: Royalty Pharma Announces Pricing of $1.5 Billion of Senior Unsecured Notes, from 5:15PM ET on Monday Jun 03, 2024 by Dow Jones
5:15PM ET on Monday Jun 03, 2024 by Dow JonesDJ Royalty Pharma Cut to Neutral From Buy by UBS, from 12:00PM ET on Monday Jun 03, 2024 by Dow Jones
12:00PM ET on Monday Jun 03, 2024 by Dow Jones
May 29, 2024
DJ S&P 500 Futures Fall In Premarket Trading; Bank OZK, American Airlines Group Lag, from 7:30AM ET on Wednesday May 29, 2024 by Dow Jones
7:30AM ET on Wednesday May 29, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Royalty Pharma PLC | 16.2B | 15.1x | +1.83% |
Amneal Pharmaceuticals Inc | 2.0B | -11.5x | --- |
Catalent Inc | 10.2B | -8.7x | --- |
Jazz Pharmaceuticals PLC | 6.9B | 22.3x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Prestige Consumer Healthcare Inc | 3.4B | 16.6x | --- |
Company Information
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Contact Information
- Headquarters
- 110 East 59th StreetNEW YORK, NY, United States 10022
- Phone
- 212-883-0200
- Fax
- ---
Executives
- Chairman of the Board, Chief Executive Officer
- Pablo Legorreta
- Vice Chairman, Executive Vice President
- Christopher Hite
- Chief Financial Officer, Executive Vice President
- Terrance Coyne
- Executive Vice President - Investments and Chief Legal Officer
- George Lloyd
- Executive Vice President - Research and Investments
- Marshall Urist
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.2B |
|---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 597.4M |
Dividend Yield | 3.12% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 05-16-24 |
Pay Date | 06-14-24 |
Beta | 0.47 |
EPS | $1.78 |
Book Value | $14.61 |
P/E Ratio | 15.1x |
Price/Sales (TTM) | 7.2 |
Price/Cash Flow (TTM) | 13.6x |
Operating Margin | 41.96% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
